DRAKE PETER F

Director at DIRECT MARKETS HOLDINGS CORP. · on record since Oct 17, 2007
Director at PENWEST PHARMACEUTICALS CO · on record since Jan 4, 2006
Director at RespireRx Pharmaceuticals Inc. · on record since Feb 7, 2007
Director at NAVIDEA BIOPHARMACEUTICALS, INC. · on record since Apr 26, 2011
10% owner at Trevi Therapeutics, Inc. · on record since May 13, 2019

Insider trading activity of DRAKE PETER F

Transactions on record: 71; since Nov 4, 2003

Open-market buys: 7; $272K

Open-market sells: 0

Companies traded: 5; last filing May 13, 2019

Figures computed from official regulatory filings — .

Companies where DRAKE PETER F has traded

Trevi Therapeutics, Inc.3 tx · May 13, 2019
NAVIDEA BIOPHARMACEUTICALS, INC.8 tx · $59.9K · Jul 21, 2015
RespireRx Pharmaceuticals Inc.15 tx · $49.1K · Aug 7, 2012
DIRECT MARKETS HOLDINGS CORP.7 tx · $192.1K · May 6, 2011
PENWEST PHARMACEUTICALS CO38 tx · $22K · Sep 22, 2010

Track record of DRAKE PETER F

Open-market buys: 7

Last buy: Sep 15, 2011

Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.

Transaction history of DRAKE PETER F

Co-insiders of DRAKE PETER F

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Trevi Therapeutics, Inc.Listing on record	May 13, 2019	OtherD (derivative)	-133,153	0.00 USD	—	SEC
Trevi Therapeutics, Inc.Listing on record	May 13, 2019	OtherD (derivative)	-376,023	0.00 USD	—	SEC
Trevi Therapeutics, Inc.Listing on record	May 13, 2019	Other	62,540	—	—	SEC
NAVIDEA BIOPHARMACEUTICALS, INC.Listing unverified	Jul 21, 2015	Other	-22,000	0.01 USD	$220	SEC
NAVIDEA BIOPHARMACEUTICALS, INC.Listing unverified	Mar 30, 2015	Award	22,000	0.00 USD	—	SEC
NAVIDEA BIOPHARMACEUTICALS, INC.Listing unverified	Feb 9, 2015	Award	7,606	1.89 USD	$14.4K	SEC
NAVIDEA BIOPHARMACEUTICALS, INC.Listing unverified	Nov 12, 2014	Award	10,973	1.32 USD	$14.5K	SEC
NAVIDEA BIOPHARMACEUTICALS, INC.Listing unverified	Feb 18, 2014	Award	20,000	0.00 USD	—	SEC
NAVIDEA BIOPHARMACEUTICALS, INC.Listing unverified	Feb 26, 2013	Award	12,250	0.00 USD	—	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Aug 7, 2012	AwardD (derivative)	346,667	0.00 USD	—	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Aug 7, 2012	AwardD (derivative)	30,000	0.00 USD	—	SEC
NAVIDEA BIOPHARMACEUTICALS, INC.Listing unverified	Apr 11, 2012	Award	17,000	0.00 USD	—	SEC
NAVIDEA BIOPHARMACEUTICALS, INC.Listing unverified	Oct 18, 2011	Buy	10,000	3.08 USD	$30.8K	SEC
DIRECT MARKETS HOLDINGS CORP.Listing unverified	May 6, 2011	Award	10,000	—	—	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Mar 3, 2011	AwardD (derivative)	30,000	0.00 USD	—	SEC
PENWEST PHARMACEUTICALS COListing unverified	Sep 22, 2010	Other	-100,263	—	—	SEC
PENWEST PHARMACEUTICALS COListing unverified	Apr 5, 2010	Award	2,240	3.46	$7.8K	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Mar 4, 2010	AwardD (derivative)	30,000	0.00	—	SEC
PENWEST PHARMACEUTICALS COListing unverified	Feb 22, 2010	Award	100	2.50	$250	SEC
PENWEST PHARMACEUTICALS COListing unverified	Jan 5, 2010	Award	6,000	0.00	—	SEC
PENWEST PHARMACEUTICALS COListing unverified	Jan 5, 2010	Award	2,662	2.63	$7K	SEC
DIRECT MARKETS HOLDINGS CORP.Listing unverified	Nov 2, 2009	Award	30,000	—	—	SEC
PENWEST PHARMACEUTICALS COListing unverified	Oct 5, 2009	Award	3,286	2.13	$7K	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Aug 24, 2009	AwardD (derivative)	30,000	0.00	—	SEC
PENWEST PHARMACEUTICALS COListing unverified	Jul 2, 2009	Award	2,536	0.00	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Trevi Therapeutics, Inc.Listing on record	May 13, 2019	OtherD (derivative)	-133,153	0.00 USD	—	SEC
Trevi Therapeutics, Inc.Listing on record	May 13, 2019	OtherD (derivative)	-376,023	0.00 USD	—	SEC
Trevi Therapeutics, Inc.Listing on record	May 13, 2019	Other	62,540	—	—	SEC
NAVIDEA BIOPHARMACEUTICALS, INC.Listing unverified	Jul 21, 2015	Other	-22,000	0.01 USD	$220	SEC
NAVIDEA BIOPHARMACEUTICALS, INC.Listing unverified	Mar 30, 2015	Award	22,000	0.00 USD	—	SEC
NAVIDEA BIOPHARMACEUTICALS, INC.Listing unverified	Feb 9, 2015	Award	7,606	1.89 USD	$14.4K	SEC
NAVIDEA BIOPHARMACEUTICALS, INC.Listing unverified	Nov 12, 2014	Award	10,973	1.32 USD	$14.5K	SEC
NAVIDEA BIOPHARMACEUTICALS, INC.Listing unverified	Feb 18, 2014	Award	20,000	0.00 USD	—	SEC
NAVIDEA BIOPHARMACEUTICALS, INC.Listing unverified	Feb 26, 2013	Award	12,250	0.00 USD	—	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Aug 7, 2012	AwardD (derivative)	346,667	0.00 USD	—	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Aug 7, 2012	AwardD (derivative)	30,000	0.00 USD	—	SEC
NAVIDEA BIOPHARMACEUTICALS, INC.Listing unverified	Apr 11, 2012	Award	17,000	0.00 USD	—	SEC
NAVIDEA BIOPHARMACEUTICALS, INC.Listing unverified	Oct 18, 2011	Buy	10,000	3.08 USD	$30.8K	SEC
DIRECT MARKETS HOLDINGS CORP.Listing unverified	May 6, 2011	Award	10,000	—	—	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Mar 3, 2011	AwardD (derivative)	30,000	0.00 USD	—	SEC
PENWEST PHARMACEUTICALS COListing unverified	Sep 22, 2010	Other	-100,263	—	—	SEC
PENWEST PHARMACEUTICALS COListing unverified	Apr 5, 2010	Award	2,240	3.46	$7.8K	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Mar 4, 2010	AwardD (derivative)	30,000	0.00	—	SEC
PENWEST PHARMACEUTICALS COListing unverified	Feb 22, 2010	Award	100	2.50	$250	SEC
PENWEST PHARMACEUTICALS COListing unverified	Jan 5, 2010	Award	6,000	0.00	—	SEC
PENWEST PHARMACEUTICALS COListing unverified	Jan 5, 2010	Award	2,662	2.63	$7K	SEC
DIRECT MARKETS HOLDINGS CORP.Listing unverified	Nov 2, 2009	Award	30,000	—	—	SEC
PENWEST PHARMACEUTICALS COListing unverified	Oct 5, 2009	Award	3,286	2.13	$7K	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Aug 24, 2009	AwardD (derivative)	30,000	0.00	—	SEC
PENWEST PHARMACEUTICALS COListing unverified	Jul 2, 2009	Award	2,536	0.00	—	SEC